Remission induction comparing infliximab and high-dose intravenous steroid, followed by treat-to-target: a double-blind, randomised, controlled trial in new-onset, treatment-naive, rheumatoid arthritis (the IDEA study). (Q46605974)
Jump to navigation
Jump to search
scientific article published on 2 August 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Remission induction comparing infliximab and high-dose intravenous steroid, followed by treat-to-target: a double-blind, randomised, controlled trial in new-onset, treatment-naive, rheumatoid arthritis (the IDEA study). |
scientific article published on 2 August 2013 |
Statements
1 reference
Remission induction comparing infliximab and high-dose intravenous steroid, followed by treat-to-target: a double-blind, randomised, controlled trial in new-onset, treatment-naive, rheumatoid arthritis (the IDEA study). (English)
1 reference
1 reference
M H Buch
1 reference
J L Nam
1 reference
E Villeneuve
1 reference
H I Keen
1 reference
A K Gough
1 reference
M J Green
1 reference
P S Helliwell
1 reference
A M Keenan
1 reference
A W Morgan
1 reference
M Quinn
1 reference
R Reece
1 reference
D M van der Heijde
1 reference
2 August 2013
1 reference
1 reference
73
1 reference
1
1 reference
75-85
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference